Collectively, our findings suggest that Periostin ablation was not sufficient to abrogate the promotion of tumor growth following cardiac remodeling, due to the elevation of multiple growth factors that include pro-inflammatory and tumorigenic cytokines and Fibronectin. This evidence concerns the gene POSTN and neoplasm.